Hospitals, insurers want rebate rule changed to keep pharma honest
Insurers and hospitals want the CMS to amend its proposed rule eliminating the safe harbor for Medicare Part D and Medicaid managed-care drug rebates to include new requirements for drugmakers.
The new rule would create a system "in which transparent, upfront discounts benefit patients, rather than a system driven by rebates that may not be used to directly benefit patients using the medicines for which the rebate is paid"
若您有更多關於健康保險的相關問題，歡迎諮詢！ If you have more question about health insurance, feel free to contact us!
電話 Phone: 626-912-1988 Email: email@example.com